REGINfo: GALAPAGOS - Pharmacie - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DELEK GROUP
- DISCOUNT
- ELBIT SYSTEMS
- Energean Oil Gas
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- LivePerson
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- Phoenix Group Holdings
- POALIM
- SHUFERSAL
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

COMPANY SEARCH RESULT

$GALAPAGOS: Click to view the issuer\'s details$

Last update : 21/08/2018 >View issuer details

2020.11.30 | 22:01 | Permanent Information Releases / General Company News

puce Galapagos rapporteert positieve topline resultaten met GLPG1205 bij patiënten met IPF in PINTA-studie - HTML (w)

2020.11.30 | 22:01 | Permanent Information Releases / Sales and Revenues

puce Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial - HTML (w)

2020.11.23 | 22:15 | Permanent Information Releases / General Company News

puce Selvita to acquire Fidelta from Galapagos - HTML (w)

2020.11.23 | 22:15 | Permanent Information Releases / General Company News

puce Selvita neemt Fidelta over van Galapagos - HTML (w)

2020.11.09 | 22:01 | Permanent Information Releases / General Company News

puce First patient dosed with GLPG3667 in psoriasis patient Phase 1b trial - HTML (w)

2020.11.09 | 22:01 | Permanent Information Releases / General Company News

puce Eerste patiënt gedoseerd met GLPG3667 in fase 1b-studie bij patiënten met psoriasis - HTML (w)

2020.11.05 | 22:15 | Permanent Information Releases / General Company News

puce OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis - HTML (w)

2020.11.05 | 22:15 | Permanent Information Releases / General Company News

puce OncoArendi en Galapagos gaan exclusieve samenwerking aan voor chitinase remmers in fibrose - HTML (w)

2020.11.05 | 22:01 | Permanent Information Releases / General Company News

puce Galapagos rapporteert derde kwartaalresultaten 2020 - HTML (w)

2020.11.05 | 22:01 | Periodic information / 3rd Quarter Information

puce Galapagos reports Q3 2020 results - HTML (w)

2020.11.02 | 22:01 | Permanent Information Releases / General Company News

puce EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF ULCERATIVE COLITIS - HTML (w)

2020.11.02 | 22:01 | Permanent Information Releases / General Company News

puce HET EUROPEES GENEESMIDDELENAGENTSCHAP GEEFT GOEDKEURING VOOR HET AANVRAGEN VAN EEN VERGUNNING VOOR FILGOTINIB VOOR DE BEHANDELING VAN COLITIS ULCEROSA - HTML (w)

2020.10.27 | 16:20 | Permanent Information Releases / General Company News

puce Galapagos’ R&D Roundtable showcases Toledo program - HTML (w)

2020.10.27 | 16:20 | Permanent Information Releases / General Company News

puce Galapagos R&D Roundtable onthult Toledo-programma - HTML (w)

2020.10.15 | 22:19 | Permanent Information Releases / General Company News

puce Galapagos en Servier rapporteren topline resultaten van ROCCELLA fase 2-studie met GLPG1972/S201086 bij patiënten met artrose in de knie - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 282